Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3401
Bausch + Lomb
BLCO
$7.15B
| $2.93M | ﹤0.01% |
176,740
-126,423
| -42% | -$2.01M |
2025 Q4
2 quarters
|
|
3402
PUT
Upstart Holdings
UPST
$2.17B
| $2.92M | ﹤0.01% |
82,500
-27,800
| -25% | -$857K |
2024 Q3
7 quarters
|
|
3403
Eupraxia Pharmaceuticals
EPRX
$455M
| $2.92M | ﹤0.01% |
+441,586
| New | +$3.04M |
2026 Q2
0 quarters
|
|
3404
CALL
IQVIA
IQV
$44.8B
| $2.92M | ﹤0.01% |
15,100
+2,300
| +18% | +$401K |
2025 Q1
5 quarters
|
|
3405
Methode Electronics
MEI
$384M
| $2.9M | ﹤0.01% |
152,916
-22,208
| -13% | -$229K |
2021 Q3
19 quarters
|
|
3406
CALL
SELLAS Life Sciences
SLS
$1.7B
| $2.9M | ﹤0.01% |
196,200
-20,000
| -9% | -$138K |
2026 Q1
1 quarter
|
|
3407
Winmark
WINA
$944M
| $2.89M | ﹤0.01% |
6,839
+2,120
| +45% | +$829K |
2023 Q4
10 quarters
|
|
3408
iBio
IBIO
$47.5M
| $2.89M | ﹤0.01% |
1,651,473
+101,623
| +7% | +$182K |
2026 Q1
1 quarter
|
|
3409
Standard BioTools
LAB
$251M
| $2.89M | ﹤0.01% |
3,512,665
+1,410,650
| +67% | +$1.33M |
2017 Q2
36 quarters
|
|
3410
Vanguard Total World Stock ETF
VT
$78.7B
| $2.89M | ﹤0.01% |
18,400
-36,932
| -67% | -$5.63M |
2026 Q1
1 quarter
|
|
3411
CALL
Darden Restaurants
DRI
$25.6B
| $2.88M | ﹤0.01% |
14,000
-3,700
| -21% | -$741K |
2022 Q3
15 quarters
|
|
3412
PUT
Elbit Systems
ESLT
$32B
| $2.88M | ﹤0.01% |
3,800
-2,500
| -40% | -$2.08M |
2026 Q1
1 quarter
|
|
3413
Absci
ABSI
$1.75B
| $2.88M | ﹤0.01% |
248,701
-948,668
| -79% | -$5.34M |
2022 Q2
16 quarters
|
|
3414
PUT
Fluor
FLR
$6.22B
| $2.88M | ﹤0.01% |
+55,000
| New | +$2.69M |
2026 Q2
0 quarters
|
|
3415
PUT
Twist Bioscience
TWST
$8.01B
| $2.88M | ﹤0.01% |
+28,000
| New | +$1.82M |
2026 Q2
0 quarters
|
|
3416
CALL
Allstate
ALL
$64.4B
| $2.88M | ﹤0.01% |
12,100
-20,000
| -62% | -$4.35M |
2023 Q4
10 quarters
|
|
3417
CALL
Pultegroup
PHM
$25.2B
| $2.87M | ﹤0.01% |
20,900
+17,100
| +450% | +$2.08M |
2022 Q3
15 quarters
|
|
3418
Invest Green Acquisition Corp
IGAC
$242M
| $2.86M | ﹤0.01% |
286,000
| – | – |
2026 Q1
1 quarter
|
|
3419
Broadstone Net Lease
BNL
$3.36B
| $2.86M | ﹤0.01% |
138,503
+79,428
| +134% | +$1.6M |
2020 Q3
23 quarters
|
|
3420
PUT
-1x Short VIX Futures ETF
SVIX
$92.8M
| $2.85M | ﹤0.01% |
+120,000
| New | +$2.42M |
2026 Q2
0 quarters
|
|
3421
Enovix
ENVX
$606M
| $2.85M | ﹤0.01% |
469,456
-1,649,852
| -78% | -$10.9M |
2023 Q4
10 quarters
|
|
3422
CALL
Vanguard Morningstar Total Stock Market ETF
VTI
$667B
| $2.85M | ﹤0.01% |
+7,700
| New | +$2.75M |
2026 Q2
0 quarters
|
|
3423
Everforth Inc
EFOR
$1.41B
| $2.84M | ﹤0.01% |
+159,149
| New | +$3.89M |
2026 Q2
0 quarters
|
|
3424
Jackson Financial
JXN
$8.7B
| $2.84M | ﹤0.01% |
27,771
+22,574
| +434% | +$2.45M |
2021 Q3
19 quarters
|
|
3425
RXO
RXO
$4.55B
| $2.84M | ﹤0.01% |
+102,926
| New | +$2.27M |
2026 Q2
0 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.